Loading...
Mixed Asset Passive

RISE Healthcare Fixed Income Balanced (253290)

Update : 2024.10.04

NAV

12,452KRW

+119.8상승 (0.97%)

Market Price per share (KRW)

12,460KRW

+130상승 (1.05%)

※ t-1 last price

trading volume

22,492shares

AUM

KRW 14.9billion

RISE Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2024.10.04
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare Fixed Income Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 14,942,567,213
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 12,460
※ t-1 last price
12,452 22,492
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency 다운로드 버튼
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare Fixed Income Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
14,942,567,213 하나은행
Market Price per share (KRW) iNAV per share (KRW)
12,460
※ t-1 last price
12,452
Trading Volume (shares)
22,492
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2024-10-04
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB03250-2903(24-1) 26.12
2 KTB03875-2612(23-10) 20.97
3 RISE HealthCare 12.81
4 원화예금 8.51
5 KTB03250-2706(24-4) 6.91
6 KTB01875-2412(21-10) 3.39
7 Alteogen 3.01
8 F 202412 2.88
9 Yuhan 2.62
10 HLB 2.30

proportion by sectors

*The proportion of investment stocks

Update : 2024.10.04
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2024-06-07 2024-06-11 40
2023-12-08 2023-12-12 110
2023-06-08 2023-06-12 40
2022-12-08 2022-12-12 91
2022-06-09 2022-06-13 16
2021-12-09 2021-12-13 11

Performance

performance

excel download

Update : 2024-10-04

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 1.91 6.70 5.60 17.10 4.58 7.87 28.20
Benchmark Index 1.90 6.74 6.32 18.21 6.95 8.70 33.92
Outperformance 0.01 -0.05 -0.73 -1.11 -2.37 -0.83 -5.73

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2024.10.04 12,460 1.054상승 12,452.14 0.971상승
2024.10.02 12,330 -0.444하락 12,331.9 -0.223하락
2024.09.30 12,385 - 12,359.07 -0.225하락
2024.09.27 12,385 -1.157하락 12,386.07 -1.054하락
2024.09.26 12,530 0.804상승 12,518.02 0.545상승
2024.09.25 12,430 -1.388하락 12,450.12 -1.156하락
2024.09.24 12,605 0.278상승 12,595.85 0.272상승
2024.09.23 12,570 0.479상승 12,561.63 0.085상승
2024.09.20 12,510 1.009상승 12,549.97 1.155상승
2024.09.19 12,385 0.855상승 12,406.59 1.009상승
2024.09.13 12,280 0.326상승 12,280.43 0.452상승
2024.09.12 12,240 0.740상승 12,225.07 0.559상승
2024.09.11 12,150 -0.450하락 12,157.03 -0.292하락
2024.09.10 12,205 0.246상승 12,192.71 0.140상승
2024.09.09 12,175 0.205상승 12,175.59 0.246상승
2024.09.06 12,150 0.041상승 12,144.77 -0.069하락

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 KTB03250-2903(24-1) KR103501GE31 633,333,333 26.12 644,329,899
2 KTB03875-2612(23-10) KR103501GDC8 500,000,000 20.97 517,160,500
3 RISE HealthCare KR7253280002 21,141 12.81 316,057,950
4 원화예금 KRD010010001 209,860,504 8.51 209,860,504
5 KTB03250-2706(24-4) KR103501GE64 166,666,667 6.91 170,378,500
6 KTB01875-2412(21-10) KR103501GBC2 83,333,333 3.39 83,687,249
7 Alteogen KR7196170005 221 3.01 74,256,000
8 F 202412 KR4165VC0007 0.67 2.88 70,950,214
9 Yuhan KR7000100008 464 2.62 64,635,200
10 HLB KR7028300002 672 2.3 56,851,200
11 SAMSUNG BIOLOGICS KR7207940008 56 2.22 54,712,000
12 Celltrion KR7068270008 234 1.81 44,694,000
13 SKBP KR7326030004 227 0.95 23,403,700
14 HanmiPharm KR7128940004 63 0.81 19,908,000
15 SCD KR7000250001 116 0.65 16,019,600
16 HANALL BIOPHARMA KR7009420001 294 0.45 10,995,600
17 Celltrionph KR7068760008 159 0.44 10,907,400
18 PharmaResearch KR7214450009 51 0.4 9,822,600
19 SKBS KR7302440003 177 0.38 9,469,500
20 ST Pharm KR7237690003 86 0.35 8,643,000
21 MedyTox KR7086900008 45 0.34 8,338,500
22 CLASSYS KR7214150005 142 0.31 7,753,200
23 CHONGKUNDANG KR7185750007 68 0.3 7,473,200
24 Hanmi Science KR7008930000 221 0.28 6,928,350
25 GC Corp KR7006280002 46 0.27 6,702,200
26 SEEGENE KR7096530001 267 0.26 6,394,650
27 CHA Biotech KR7085660009 331 0.23 5,610,450
28 HLBPHARMA KR7047920004 225 0.23 5,760,000
29 HK inno.N KR7195940002 118 0.23 5,758,400
30 Binex KR7053030003 233 0.22 5,533,750
31 DAEWOONG PHARM KR7069620003 38 0.21 5,149,000
32 BIONEER KR7064550007 185 0.2 5,004,250
33 DENTIUM KR7145720009 55 0.18 4,389,000
34 ShinpoongPharm KR7019170000 275 0.14 3,349,500
35 DongKook Pharm KR7086450004 193 0.13 3,325,390
36 Donga ST KR7170900005 42 0.12 2,944,200
37 i-SENS KR7099190001 174 0.12 3,031,080
38 JWPHARMA KR7001060003 111 0.12 3,058,050
39 T&L KR7340570001 38 0.11 2,717,000
40 WONTECH KR7336570007 358 0.1 2,445,140
41 L&C BIO KR7290650001 128 0.1 2,547,200
42 Boryung KR7003850005 246 0.1 2,573,160
43 Pharmicell KR7005690003 465 0.1 2,399,400
44 SELVAS AI KR7108860008 197 0.09 2,131,540
45 Amicogen KR7092040005 408 0.08 1,858,440
46 GC CELL KR7144510005 66 0.08 2,079,000
47 CUREXO KR7060280005 241 0.07 1,817,140
48 KwangdongPharm KR7009290008 263 0.06 1,504,360
49 Aprogen KR7007460009 1,123 0.05 1,322,894
50 Ray KR7228670006 93 0.03 777,480
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.